Form 4 for USPH U S PHYSICAL THERAPY INC /NV
Accepted 2023-02-23 00:00:00 ET · period of report 2023-02-20 · accession 0001209191-23-012195 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-23 | 2023-02-20 | USPH | Binstein Richard | EVP Gen'l Counsel, Sec | A - Grant | $0.00 | +3,750 | 10.8K | +53% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-20 | A | A | 3,750 | $0.00 | 10,817 | D | — | — | (F1) The 3,750 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 quarterly installments with 234 shares vesting on the first day of each of the succeeding fifteen quarters beginning on April 1, 2023, and with the final 240 shares vesting on January 1, 2027, if he is employed by the Company on those dates. (F2) Includes 9,906 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 968 shares on each of April 1, 2023, July 1, 2023, October 1, 2023, and January 1, 2024; 733 shares on each of April 1, 2024, July 1, 2024, and October 1, 2024; 734 shares on January 1, 2025; 539 shares on each of April 1, 2025, July 1, 2025 and October 1, 2025; 542 shares on January 1, 2026; and 234 shares on each of April 1, 2026, July 1, 2026 and October 1, 2026; with the final 240 shares on January 1, 2027, if he is an employee of the Company on those dates. |